ISUVAZ 100 contains isavuconazole, a systemic triazole antifungal medicine with broad-spectrum activity. Isavuconazole inhibits an enzyme involved in ergosterol biosynthesis, an essential component of the fungal cell membrane. Disruption of ergosterol production interferes with fungal cell membrane integrity and inhibits fungal growth.
May be prescribed for:
The medicine is intended for serious invasive fungal infections and is not intended as a routine treatment for common superficial fungal infections of the skin or nails.
Research and clinical evidence:
ISUVAZ 100 is used for the treatment of certain serious invasive fungal infections in adults, primarily invasive aspergillosis and invasive mucormycosis.
Isavuconazole inhibits lanosterol 14-alpha-demethylase, an enzyme involved in ergosterol biosynthesis. Reduced ergosterol production disrupts the fungal cell membrane and inhibits fungal growth.
The medicine is intended for systemic antifungal therapy and should be used only when a fungal infection has been confirmed or is strongly suspected by a healthcare professional.
Isavuconazole is taken orally with or without food, exactly as prescribed by a physician. The standard adult regimen includes a loading dose of isavuconazole 200 mg every 8 hours for the first 48 hours, followed by 200 mg once daily. Because each capsule contains 100 mg of isavuconazole, the number of capsules taken per dose is determined by the prescribed dose. Capsules should be swallowed whole and should not be chewed, crushed, opened, or dissolved. Treatment duration depends on the type and severity of infection, the patient's immune status, and clinical response.
Side Effects









